| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Oct―18 |
SARS-CoV-2 infects macrophages in coronary atherosclerotic plaques |
Gregory B. Lim |
| 2 |
[GO] |
2023―Jun―21 |
Author Correction: Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms |
Stephane Heymans, Leslie T. Cooper |
| 3 |
[GO] |
2023―Feb―02 |
Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome |
Artur Fedorowski, Richard Sutton |
| 4 |
[GO] |
2022―Mar―25 |
Long COVID and cardiovascular disease: a learning health system approach |
Mohamed O. Mohamed, Amitava Banerjee |
| 5 |
[GO] |
2022―Jan―13 |
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium |
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, Udaya S. Tantry, Jeffrey S. Berger, Mark Y. Chan, Daniel Duerschmied, Susan S. Smyth, William A. E. Parker, Ramzi A. Ajjan, Gemma Vilahur, Lina Badimon, Jurrien M. ten Berg, Hugo ten Cate, Flora Peyvandi, Taia T. Wang, Richard C. Becker |
| 6 |
[GO] |
2021―Dec―09 |
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms |
Stephane Heymans, Leslie T. Cooper |
| 7 |
[GO] |
2021―Dec―06 |
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective |
Sarah Halawa, Soni S. Pullamsetti, Charles R. M. Bangham, Kurt R. Stenmark, Peter Dorfmüller, Maria G. Frid, Ghazwan Butrous, Nick W. Morrell, Vinicio A. de Jesus Perez, David I. Stuart, Kevin O’Gallagher, Ajay M. Shah, Yasmine Aguib, Magdi H. Yacoub |
| 8 |
[GO] |
2021―Dec―02 |
Collateral cardiovascular damage during the COVID-19 pandemic |
Ramesh Nadarajah, Chris P. Gale |
| 9 |
[GO] |
2021―Nov―01 |
Publisher Correction: Cardiac involvement in the long-term implications of COVID-19 |
Benjamin A. Satterfield, Deepak L. Bhatt, Bernard J. Gersh |
| 10 |
[GO] |
2021―Oct―22 |
Cardiac involvement in the long-term implications of COVID-19 |
Benjamin A. Satterfield, Deepak L. Bhatt, Bernard J. Gersh |
| 11 |
[GO] |
2021―Jun―23 |
Social disparities in COVID-19 prevention |
Ciarán Martin Fitzpatrick |
| 12 |
[GO] |
2021―Apr―07 |
Preventing cardiac damage in patients with COVID-19 |
Andrew Robson |
| 13 |
[GO] |
2021―Feb―04 |
Microthrombi cause cardiac injury in COVID-19 |
Irene Fernández-Ruiz |
| 14 |
[GO] |
2021―Jan―18 |
ACEi reduces hypertension-induced hyperinflammation in COVID-19 |
Gregory B. Lim |
| 15 |
[GO] |
2020―Nov―19 |
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation |
Sean X. Gu, Tarun Tyagi, Kanika Jain, Vivian W. Gu, Seung Hee Lee, Jonathan M. Hwa, Jennifer M. Kwan, Diane S. Krause, Alfred I. Lee, Stephanie Halene, Kathleen A. Martin, Hyung J. Chun, John Hwa |
| 16 |
[GO] |
2020―Sep―01 |
The COVID-19 pandemic: a catalyst to improve clinical trials |
Prakriti Gaba, Deepak L. Bhatt |
| 17 |
[GO] |
2020―Jul―30 |
Pulling at the heart: COVID-19, race/ethnicity and ongoing disparities |
Peter Chin-Hong, Kevin M. Alexander, Norrisa Haynes, Michelle A. Albert |
| 18 |
[GO] |
2020―Jul―20 |
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives |
Masataka Nishiga, Dao Wen Wang, Yaling Han, David B. Lewis, Joseph C. Wu |
| 19 |
[GO] |
2020―Jun―25 |
Reduced hospital admissions for ACS - more collateral damage from COVID-19 |
Karina Huynh |
| 20 |
[GO] |
2020―Jun―22 |
Myocardial injury in patients with COVID-19 |
Gregory B. Lim |
| 21 |
[GO] |
2020―May―22 |
RAAS inhibitors do not increase the risk of COVID-19 |
Irene Fernández-Ruiz |
| 22 |
[GO] |
2020―Mar―30 |
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19 |
Jean-Jacques Mourad, Bernard I. Levy |
| 23 |
[GO] |
2020―Mar―30 |
Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ |
Ying-Ying Zheng, Yi-Tong Ma, Jin-Ying Zhang, Xiang Xie |
| 24 |
[GO] |
2020―Mar―05 |
COVID-19 and the cardiovascular system |
Ying-Ying Zheng, Yi-Tong Ma, Jin-Ying Zhang, Xiang Xie |
